Sarah de Ferranti, MD, MPH
Better understanding of the role of
inflammation in atherosclerotic risk in children is the career goal of Dr.
Sarah de Ferranti. Her clinical work centers on the evaluation and treatment of
children at risk for early atherosclerosis.
Director of the Preventive
Cardiology Clinic at Children’s Hospital Boston, Dr. de Ferranti is pursuing
the identification of tools that can refine risk prediction in childhood of
early atherosclerosis in adulthood.
Born in
The focus of her current work is a
randomized trial of two nutritional treatments of overweight adolescents with
cardiovascular risk factors, including effects on inflammation, oxidative
stress and vascular function. This is supported by K23 funding from NHLBI.
In her SADF-funded research, Dr. de
Ferranti describes children with and without family history of early
atherosclerosis and their inflammatory profiles. Her research finds no
relationship between family history of early atherosclerosis and inflammatory
profiles of children or their parent. Also, no relationship was found between
inflammatory profiles and lipid profiles in either group, child or parent.
Subsequent analysis has revealed that the relationships may, however, be
present based on obesity.
She and her husband are raising
three young children, in
Email: Sarah.DeFerranti@CARDIO.CHBOSTON.ORG
Phone:
617-355-0955